Emerging Enterprise Center Blog - Commentary and Analysis For Entrepreneurs and Startups

Prithvi Tanwar Associate

• PTanwar@foleyhoag.com
• Subscribe to Prithvi Tanwar

Prithvi Tanwar is an Associate in the firm’s Business Department. His practice focuses on advising emerging life science and technology companies as well as U.S. and foreign venture capital firms on financing transactions, technology transfer, mergers and acquisitions and general corporate matters.

Before attending law school, Prithvi worked for several years as a management and technology consultant with Cap Gemini Ernst & Young and Deloitte where he helped Fortune 500 clients implement information technology solutions and refine their business processes. During law school Prithvi was a teaching assistant at a Boston University MBA class on systems analysis and design. During this time, he was also a law clerk for a retired immigration judge’s private practice, where he worked mainly on refugee asylum and immigration matters.

Practice Areas

• Venture Capital & Emerging Companies
• Business
• Mergers and Acquisitions
• International

Professional Associations

• Boston Bar Association, Member
• AILA, 2006-2007

Education

• Boston University School of Law, J.D., 2008
• Drake University, B.S. in Business Administration, summa cum laude, 2001

Bar Admissions

• Massachusetts

Foley Hoag Venture Perspectives

New York and New England Q1 Venture Statistics -- a quick preview

We are about to publish our first review of New York transactions.  Here is the sneak preview: 

With respect to series A deals, New York and New England each had 22 deals in Q1.  According to us, there were 223 series A deals nationally.  So, NY and NE collectively represented approximately 20% of the national market.

With respect to later stage transactions, there were 25 NY deals and 43 NE deals.  Again, according to us there were 368 deals nationally.  So collectively NY and NE represent about 18% of the market.

I imagine that the relatively smaller number of later stage deals in New York reflects a number of things.  One might be that the boom in NY deals is relatively recent so there may not be as many companies in the pipeline that are ready for a second or later round investment.  Another might be that the mix of investment opportunities in New York is more “capital efficient” than in NE (and maybe other places).

With respect to that later point, here is a breakdown of some categories.  We categorize deals into one of four categories technology, life science, cleantech and other. 

With respect to series A deals in NE in Q1 40% of deals were in the technology category, 14% were in life science and the rest were other.  That is there were no cleantech deals.  In NY 30% were technology and 70% were other.  There were no life science or cleantech deals.

With respect to later stage deals, in NE 37% were life science and 35% were technology.  In NY 72% were other and 16% were technology.

I suspect that most of the other deals in NY were companies with revenue models based on advertising revenue. 

All this leads to the conclusion that NY is a pretty exciting place for investors.  I predict that the upswing in NY deals will continue.  Stats over the next few quarters will tell the story.

EEC Events Calendar

Subscribe

Add this blog to your feeds or subscribe by email using the form below

About Us

The Emerging Enterprise Center Blog is where we plan to cover a wide range of topics that arise from our...